Loading…
Pharmasi+ (ფარმასი +) — despite the pharma-sounding name, this is a perfume/fragrance wholesale and retail business (analyst-confirmed), not a pharmaceutical company. Reclassified to Retail - Apparel & Specialty (Perfume & Cosmetics). Stable, healthy margins (~55%).
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 3,794 | 3,778 | 4,808 | 3,830 | 3,523 | 3,141 | -3.7% |
| Total COGS | 1,780 | 1,600 | 1,975 | 1,643 | 1,543 | 1,488 | -3.5% |
| Gross Profit | 2,014 | 2,178 | 2,832 | 2,187 | 1,980 | 1,653 | -3.9% |
| Gross Margin | 53.1% | 57.6% | 58.9% | 57.1% | 56.2% | 52.6% | |
| 829 | 913 | 1,341 | 1,507 | 1,549 | 1,464 | +12.0% | |
| EBITDA | 1,185 | 1,265 | 1,492 | 680 | 431 | 189 | -30.7% |
| EBITDA Margin | 31.2% | 33.5% | 31.0% | 17.7% | 12.2% | 6.0% | |
| Total D&A | 5 | 7 | 27 | 39 | 43 | 46 | +59.0% |
| EBIT / Operating Income | 1,181 | 1,257 | 1,465 | 641 | 388 | 143 | -34.5% |
| Total Interest Expense | 19 | 34 | 43 | 19 | 10 | 27 | +7.7% |
| 310 | 439 | 373 | 85 | 11 | 69 | nmf | |
| Profit Before Tax | 852 | 784 | 1,049 | 537 | 367 | 185 | -26.3% |
| Total Income Tax | 177 | 111 | 154 | 57 | 32 | 70 | -16.9% |
| Net Profit / (Loss) | 675 | 674 | 895 | 480 | 335 | 115 | -29.9% |
| Net Margin | 17.8% | 17.8% | 18.6% | 12.5% | 9.5% | 3.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →